Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about CX3CL1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
| Gene Symbol | CX3CL1 |
| Full Name | Fractalkine (C-X3-C Motif Chemokine Ligand 1) |
| Aliases | C-X3-C Motif Chemokine Ligand 1 |
| Chromosome | 16q13 |
| Primary Expression | Neurons (cortex, hippocampus), Endothelial cells, Dendritic cells |
| Amino Acids | 373 aa |
| Pathways | Neuroinflammatory |
| UniProt ID | P78423 |
| NCBI Gene ID | 6376 |
| Ensembl ID | ENSG00000006210 |
| OMIM | 601880 |
| GeneCards | CX3CL1 |
| Human Protein Atlas | CX3CL1 |
| Associated Diseases | Als, Alzheimer, Alzheimer's disease, Amyotrophic Lateral Sclerosis |
| Interactions | AGING, AKT, ALZHEIMER, ALZHEIMER'S DISEASE, AMPK, AMYLOID |
| KG Connections | 484 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
CX3CL1["CX3CL1"]
CX3CL1 -->|"expressed in"| Neurodegeneration["Neurodegeneration"]
CX3CL1 -->|"regulates"| Inflammation["Inflammation"]
CX3CL1 -->|"regulates"| Neuroinflammation["Neuroinflammation"]
CX3CL1 -->|"target for"| Aging["Aging"]
CX3CL1 -->|"interacts"| Ms["Ms"]
CX3CL1 -.biomarker for.-> Senescence["Senescence"]
CX3CL1 -.biomarker for.-> Als["Als"]
CX3CL1 -.biomarker for.-> Longevity["Longevity"]
CX3CR1["CX3CR1"] -->|"target for"| CX3CL1
FGF21["FGF21"] -->|"activates"| CX3CL1
APP["APP"] -.biomarker for.-> CX3CL1
FNDC5["FNDC5"] -->|"activates"| CX3CL1
S100B["S100B"] -.biomarker for.-> CX3CL1
PLAU["PLAU"] -->|"activates"| CX3CL1
CXCL10["CXCL10"] -->|"activates"| CX3CL1
C1Q["C1Q"] -.biomarker for.-> CX3CL1
OVERVIEW["OVERVIEW"] -->|"expressed in"| CX3CL1
FGF23["FGF23"] -->|"activates"| CX3CL1| Target | Relation | Type | Str |
|---|---|---|---|
| Neurons | interacts_with | cell_type | 0.95 |
| Fractalkine | associated_with | protein | 0.95 |
| Frailty | biomarker_for | phenotype | 0.95 |
| Cx3Cr1 | binds | protein | 0.95 |
| Neuroinflammation | modulates | process | 0.95 |
| Microglial activation | modulates | process | 0.90 |
| Blood-Brain Barrier | regulates | brain_region | 0.90 |
| Microglia | interacts_with | cell_type | 0.90 |
| Neuron-Glial Signaling | mediates | pathway | 0.90 |
| CX3CR1/AMPK/PPARG Pathway | activates | pathway | 0.90 |
| Neuron-Glial Signaling | involved_in | pathway | 0.90 |
| NEURON | expressed_in | cell_type | 0.90 |
| Neurons | expressed_in | cell_type | 0.90 |
| Hematoma Resolution | associated_with | process | 0.85 |
| Neurodegeneration | targets | disease | 0.85 |
| Frailty | biomarker_for | phenotype | 0.85 |
| Germinal Matrix Hemorrhage | protects_against | disease | 0.85 |
| neurodegeneration | associated_with | process | 0.85 |
| Neurodegenerative Diseases | therapeutic_target | disease | 0.85 |
| neurodegenerative disease | implicated_in | disease | 0.80 |
| neurodegenerative diseases | targets | disease | 0.80 |
| GNB5 | regulates | protein | 0.80 |
| microglia | expressed_in | cell_type | 0.80 |
| Inflammation | activates | disease | 0.75 |
| CX3CR1 | expressed_in | gene | 0.70 |
| NEURONS | expressed_in | cell_type | 0.70 |
| NEURONS | activates | cell_type | 0.70 |
| NEURONS | mediates | cell_type | 0.70 |
| CXCL10 | biomarker_for | gene | 0.70 |
| MICROGLIA | expressed_in | cell_type | 0.70 |
| NEURONS | transports | cell_type | 0.70 |
| STAT3 | activates | gene | 0.70 |
| TREM2 | associated_with | gene | 0.70 |
| MICROGLIA | transports | cell_type | 0.70 |
| MICROGLIA | mediates | cell_type | 0.70 |
| MICROGLIA | regulates | cell_type | 0.70 |
| CX3CR1 | transports | gene | 0.70 |
| STING | biomarker_for | gene | 0.70 |
| MACROPHAGE | disrupts | cell_type | 0.70 |
| ENDOTHELIAL | targets | cell_type | 0.70 |
| MACROPHAGE | targets | cell_type | 0.70 |
| MACROPHAGE | interacts_with | cell_type | 0.70 |
| ENDOTHELIAL | activates | cell_type | 0.70 |
| microglial activation | modulates | mechanism | 0.70 |
| motor neuron survival | protective_against | process | 0.70 |
| microglia | modulates | cell_type | 0.70 |
| neurons | expressed_in | cell_type | 0.70 |
| Cx3Cr1 | associated_with | protein | 0.70 |
| Tauopathy | inhibits | disease | 0.65 |
| Dementia | inhibits | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Repetitive Transcranial Magnetic Stimulation | upregulates | drug | 0.92 |
| GABAergic Neuron | produces | cell_type | 0.90 |
| h-494861d2 | targets | hypothesis | 0.90 |
| miR-16-5p | downregulates | biomarker | 0.85 |
| miR-125b-5p | downregulates | biomarker | 0.85 |
| ADAM10 | regulates | gene | 0.70 |
| CCL2 | regulates | gene | 0.70 |
| ASTROCYTE | reduces | cell_type | 0.65 |
| APP/PS1 | activates | gene | 0.60 |
| NEUROINFLAMMATION | activates | gene | 0.60 |
| MICROGLIA | inhibits | gene | 0.60 |
| PARKINSON'S DISEASE | associated_with | gene | 0.60 |
| NEURODEGENERATIVE DISEASES | therapeutic_target | gene | 0.60 |
| NEURODEGENERATION | expressed_in | gene | 0.60 |
| ALZHEIMER'S DISEASE | associated_with | gene | 0.60 |
| HUNTINGTON'S DISEASE | associated_with | gene | 0.60 |
| AMYOTROPHIC LATERAL SCLEROSIS | associated_with | gene | 0.60 |
| BRAIN INJURY | associated_with | gene | 0.60 |
| ALZHEIMER'S DISEASE | therapeutic_target | gene | 0.60 |
| NEUROINFLAMMATION | contributes_to | gene | 0.60 |
| CANCER | activates | gene | 0.60 |
| MICROGLIA | regulates | gene | 0.60 |
| ASTROCYTES | activates | gene | 0.60 |
| DIABETIC RETINOPATHY | activates | gene | 0.60 |
| MICROGLIA | interacts_with | gene | 0.60 |
| NF-ΚB | inhibits | gene | 0.60 |
| AD | co_discussed | gene | 0.60 |
| INFLAMMATION | activates | gene | 0.60 |
| WNT | inhibits | gene | 0.60 |
| TAUOPATHY | inhibits | gene | 0.60 |
| AGING | therapeutic_target | gene | 0.60 |
| AMYLOID | inhibits | gene | 0.60 |
| CX3CR1 | expressed_in | gene | 0.60 |
| SYNAPSE | inhibits | gene | 0.60 |
| CXCL10 | activates | gene | 0.60 |
| C1Q | biomarker_for | gene | 0.60 |
| CXCR1 | associated_with | gene | 0.60 |
| OVERVIEW | expressed_in | gene | 0.60 |
| FGF23 | activates | gene | 0.60 |
| GPNMB | biomarker_for | gene | 0.60 |
| BDNF | activates | gene | 0.60 |
| RAGE | activates | gene | 0.60 |
| LGALS3 | activates | gene | 0.60 |
| BLM | activates | gene | 0.60 |
| CCL20 | regulates | gene | 0.60 |
| STAT3 | regulates | gene | 0.60 |
| CTSB | activates | gene | 0.60 |
| CTSL | activates | gene | 0.60 |
| CTSS | activates | gene | 0.60 |
| JAK2 | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| GluN2B-CX3CL1 Axis Controls Microglial Tau Phagocytosis | 0.761 | neuroscience | GluN2B-Mediated Thalamocortical Control |
| CX3CL1-CX3CR1 Mimetic Therapy for Neuroprotection | 0.635 | neurodegeneration | Microglial subtypes in neurodegeneration |
| Soluble CX3CL1 cleavage by ADAM proteases disengages fractal | 0.540 | neurodegeneration | Synaptic pruning by microglia in neurode |
| CX3CL1 Mimetic Peptide to Disrupt Fractalkine Signaling Dysr | 0.459 | immunomics | Systemic immune profiling in neurodegene |
Scientific analyses that reference this entity
neuroscience | 2026-04-28 | 7 hypotheses Top: 0.808
neurodegeneration | 2026-04-26 | 8 hypotheses Top: 0.861
neurodegeneration | 2026-04-17 | 7 hypotheses Top: 0.685
neurodegeneration | 2026-04-12 | 0 hypotheses
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.703
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
active · Rounds: 4 · Score: 0.82 · 2026-04-28
closed · Rounds: 6 · Score: 0.95 · 2026-04-27
closed · Rounds: 4 · Score: 0.50 · 2026-04-27
closed · Rounds: 4 · Score: 0.64 · 2026-04-26
closed · Rounds: 4 · Score: 0.50 · 2026-04-26
closed · Rounds: 4 · Score: 0.92 · 2026-04-26
closed · Rounds: 4 · Score: 0.49 · 2026-04-18
closed · Rounds: 4 · Score: 0.50 · 2026-04-18
closed · Rounds: 4 · Score: 0.95 · 2026-04-06
Hypotheses and analyses mentioning CX3CL1 in their description or question text
No additional research found